Compare BELFA & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BELFA | INSP |
|---|---|---|
| Founded | 1949 | 2007 |
| Country | United States | United States |
| Employees | 4964 | 1333 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.6B |
| IPO Year | N/A | 2018 |
| Metric | BELFA | INSP |
|---|---|---|
| Price | $231.50 | $55.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | ★ $174.25 | $94.00 |
| AVG Volume (30 Days) | 68.1K | ★ 814.3K |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.10% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | N/A | ★ 4.89 |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $9.74 | $8.02 |
| Revenue Next Year | $6.34 | $8.11 |
| P/E Ratio | $40.02 | ★ $11.37 |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $62.00 | $48.30 |
| 52 Week High | $255.04 | $163.35 |
| Indicator | BELFA | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 60.05 | 49.52 |
| Support Level | $114.22 | $52.37 |
| Resistance Level | N/A | $60.15 |
| Average True Range (ATR) | 11.29 | 2.64 |
| MACD | -0.34 | 0.23 |
| Stochastic Oscillator | 57.44 | 54.15 |
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.